Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Peripheral Blood Stem Cell (PBSC) Mobilization in Patients With Relapsed Lymphoma Treated With Bendamustine
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy
- Status
- COMPLETED
- Phase
- PHASE4
Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide
- Status
- COMPLETED
- Phase
- PHASE2
CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1a)
- Status
- COMPLETED
- Phase
- PHASE3
Study With Rituximab, Cyclophosphamide, Doxorubicin Liposomal (Myocet®), Vincristine, Prednisone, (R-COMP) to Treat Non-Hodgkin's Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Trial of R-CHOP + Azacytidine in Diffuse Large B Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
R-ABVD vs ABVD-RT in Early Stage Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE3
Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Aggressive B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Rituximab and Combination Chemotherapy With or Without Bleomycin Sulfate in Treating Patients With Primary Mediastinal Large B-Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
A Clinical Study Using MEDI-551 in Adult Participants With Relapsed or Refractory Advanced B-Cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Rituximab in Multirelapsing Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS)
- Status
- COMPLETED
- Phase
- PHASE3
Bortezomib, Cladribine, and Rituximab in Treating Patients With Advanced Mantle Cell Lymphoma or Indolent Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2